138 studies found for:    Bronchitis: Clinical Trials
Show Display Options
Rank Status Study
1 Terminated A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis
Condition: Chronic Bronchitis
Interventions: Drug: Faropenem medoxomil;   Drug: placebo
2 Completed
Has Results
A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)
Condition: Chronic Bronchitis
Interventions: Other: Moxifloxacin Placebo;   Drug: Moxifloxacin;   Other: Azithromycin SR Placebo;   Drug: Azithromycin SR
3 Completed Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
Condition: Acute Bronchitis
Interventions: Drug: Theobromine 300mg;   Drug: Levodropropizine 10mg
4 Completed Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup"
Conditions: Acute Upper Respiratory Tract Infections;   Bronchitis
Intervention: Drug: AG NPP709syrup
5 Completed A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases
Condition: Acute Bronchitis
Intervention: Drug: Azithromycin SR
6 Completed A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis
Condition: Bronchitis, Chronic
Interventions: Other: placebo;   Drug: azithromycin SR (Zithromax; compound: CP-62,993);   Drug: levofloxacin
7 Active, not recruiting Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies
Conditions: Pharyngitis;   Acute Tonsillitis;   Rhinosinusitis;   Acute Bronchitis;   Chronic Obstructive Pulmonary Disease
Intervention: Other: Antibiotic prescription strategies
8 Not yet recruiting Study of the Prednisone Sparing Effect of Xolair (Omalizumab) in Patients With Prednisone-dependent Asthma With Eosinophilic Bronchitis
Conditions: Prednisone Dependent Asthma;   Eosinophilic Bronchitis
Interventions: Biological: Omalizumab (Xolair);   Drug: Placebo
9 Completed
Has Results
Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety
Condition: Diabetes Mellitus
Intervention: Drug: Randomization to Exubera (insulin human [rDNA origin] inhalation powder) or Usual Diabetes Care
10 Recruiting Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)
Conditions: Rhinosinusitis;   Acute Bronchitis;   Acute Otitis Media;   Pharyngotonsillitis
Intervention: Other: Antibiotic prescription strategies
11 Terminated Outpatient Registry Trial of Respiratory Tract Infections in Adults
Conditions: Pneumonia, Bacterial;   Bronchitis, Chronic
Interventions: Drug: azithromycin;   Drug: telithromycin;   Drug: Clarythromycin
12 Completed Greatest International Antiinfective Trial With Avelox
Conditions: Bronchitis, Chronic;   Bronchial Diseases
Intervention: Drug: Moxifloxacin (Avelox, BAY12-8039)
13 Recruiting Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis
Conditions: Chronic Obstructive Pulmonary Diseases;   Chronic Airways Limitation;   Bronchitis
Interventions: Drug: Mepolizumab;   Drug: placebo
14 Unknown  CRP-guided Antibiotic Treatment in COPD Exacerbations Admitted to the Hospital
Conditions: COPD;   Exacerbation;   Bronchitis;   Sputum;   C-Reactive Protein
Intervention: Other: CRP-guided antibiotic treatment
15 Completed Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis
Condition: Acute Bronchitis
Interventions: Drug: KALOMIN™ Tab.;   Drug: Umckamin syrup
16 Completed Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis
Conditions: Acute Bronchitis;   Chronic Bronchitis
Interventions: Drug: YHD001 dose level 1;   Drug: YHD001 dose level 2;   Drug: Pelargonium sidoides extract;   Drug: placebo
17 Completed COPD on Primary Care Treatment (COOPT)
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive;   Bronchitis, Chronic
Interventions: Drug: N-acetylcysteine;   Drug: fluticasone propionate
18 Not yet recruiting N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
Conditions: COPD;   Chronic Bronchitis
Interventions: Drug: N-Acetylcysteine;   Drug: Identical Placebo manufactured to mimic appearance of intervention drug with identical frequency and duration
19 Unknown  N-Acetylcysteine for Patients With COPD and ChronicBronchitis
Conditions: Chronic Obstructive Pulmonary Disease;   Chronic Bronchitis
Interventions: Drug: N-acetylcysteine;   Drug: Oral acetylcysteine
20 Terminated N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
Conditions: Chronic Obstructive Pulmonary Disease;   Chronic Bronchitis
Interventions: Drug: N-acetylcysteine;   Drug: Identical placebo pills twice daily for 8 weeks

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years